Woo Je Lee

Dr. Woo Je Lee


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
YLYou-Bin Lee
You-Bin Lee
GKGyuri Kim
Gyuri Kim
JJJi Eun Jun
Ji Eun Jun
HPHyunjin Park
Hyunjin Park
WLWoo Je Lee
Woo Je Lee
JKJae Hyeon Kim
Jae Hyeon Kim
OBJECTIVE: We investigated the efficacy of an integrated digital health care platform with artificial intelligence (AI)–based dietary management in adults with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: In this 48-week, open-label, randomized, multicenter clinical trial, overweight or obese adults with T2D were randomly assigned to one of three groups in a 1:1:1 ratio: group A received routine diabetes care; group B used the digital integrated health care platform by themselves; and group C used the platform with feedback from medical staff and intermittently applied personal continuous glucose monitoring. The primary end point was the difference of change in HbA1c from baseline to 24 weeks between groups A and B, while secondary end points included changes in HbA1c from baseline to 48 weeks and changes in body weight during follow-up. RESULTS: A total of 294 participants were randomly assigned to group A (n = 99), B (n = 97), or C (n = 98). The decreases in HbA1c from baseline to 24 and 48 weeks in group B (−0.32 ± 0.58% to 24 weeks and −0.28 ± 0.56% to 48 weeks) and group C (−0.49 ± 0.57% to 24 weeks and −0.44 ± 0.62% to 48 weeks) were significantly larger than those in group A (−0.06 ± 0.61% to 24 weeks and 0.07 ± 0.78% to 48 weeks). Groups B and C exhibited greater weight loss than group A from baseline to 24 weeks, and group C demonstrated more weight loss than group A from baseline to week 48. CONCLUSIONS: Among adults with T2D, use of an integrated digital health care platform with AI-driven dietary management resulted in better glycemia and more weight loss.

1 October 2015 in Kidney International
Verified
Journal Article
Closed access
PDF file
CJChang Hee Jung
Chang Hee Jung
MLMin Jung Lee
Min Jung Lee
YKYu Mi Kang
Yu Mi Kang
JHJenie Y. Hwang
Jenie Y. Hwang
EKEun Hee Kim
Eun Hee Kim
WLWoo Je Lee
Woo Je Lee

31 May 2022 in Diabetes & Metabolism Journal
Verified
Journal Article
Open access
PDF file
EKEun Hee Kim
Eun Hee Kim
HKHong-Kyu Kim
Hong-Kyu Kim
MLMin Jung Lee
Min Jung Lee
SBSung-Jin Bae
Sung-Jin Bae
JCJaewon Choe
Jaewon Choe
WLWoo Je Lee
Woo Je Lee
Background: This study aimed to determine the optimal cut-off values of visceral fat area (VFA) and visceral-to-subcutaneous fat ratio (VSR) for predicting incident type 2 diabetes mellitus (T2DM).Methods: A total of 10,882 individuals (6,835 men; 4,047 women) free of T2DM at baseline aged between 30 and 79 years who underwent abdominal computed tomography scan between 2012 and 2013 as a part of routine health check-ups were included and followed. VFA, subcutaneous fat area, and VSR on L3 vertebral level were measured at baseline.Results: During a median follow-up of 4.8 years, 730 (8.1% for men; 4.3% for women) incident cases of T2DM were identified. Receiver operating characteristic curve analysis showed that the optimal cut-off values of VFA and VSR for predicting incident T2DM were 130.03 cm2 and 1.08 in men, respectively, and 85.7 cm2 and 0.48 in women, respectively. Regardless of sex, higher VFA and VSR were significantly associated with a higher risk of incident T2DM. Compared with the lowest quartiles of VFA and VSR, the highest quartiles had adjusted odds ratios of 2.62 (95% confidence interval [CI], 1.73 to 3.97) and 1.55 (95% CI, 1.14 to 2.11) in men, respectively, and 32.49 (95% CI, 7.42 to 142.02) and 11.07 (95% CI, 3.89 to 31.50) in women, respectively.Conclusion: Higher VFA and VSR at baseline were independent risk factors for the development of T2DM. Sex-specific reference values for visceral fat obesity (VFA ≥130 cm2 or VSR ≥1.0 in men; VFA ≥85 cm2 or VSR ≥0.5 in women) are proposed for the prediction of incident T2DM.

29 December 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YCYun Kyung Cho
Yun Kyung Cho
JLJiwoo Lee
Jiwoo Lee
HKHwi Seung Kim
Hwi Seung Kim
EKEun Hee Kim
Eun Hee Kim
MLMin Jung Lee
Min Jung Lee
WLWoo Je Lee
Woo Je Lee
The triglyceride glucose (TyG) index, a product of triglyceride and fasting glucose, is a reliable marker for insulin resistance. We aimed to investigate the association between the TyG-related markers and coronary artery calcification (CAC) progression. We enrolled 1145 asymptomatic participants who underwent repeated CAC score measurements during routine health examinations. Homeostasis model assessment of insulin resistance (HOMA-IR), TyG index, TyG-BMI (body mass index), and TyG-WC (waist circumference) were calculated. Progression of CAC was defined as (1) incident CAC in a CAC-free population, or an (2) increase of ≥2.5 units between the baseline and final square root of the CAC scores in participants with detectable CAC. According to the quartiles of parameters, we stratified the subjects into four groups. The prevalence of progression increased with the TyG-WC quartile (15.0%, 24.1%, 31.0%, and 32.2% for each of the groups; p < 0.001). The multivariate-adjusted odds ratio (95% confidence interval) for CAC score progression was 1.66 (1.01–2.77) when the highest and lowest TyG-WC index quartiles were compared. Furthermore, the predictability of TyG-WC for CAC progression was better than the other indices in terms of the area under the curve. The TyG-WC index predicted CAC progression better than other indices and could be a potential marker of future coronary atherosclerosis.

23 September 2022 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
SMSun Joon Moon
Sun Joon Moon
KKKyung‐Soo Kim
Kyung‐Soo Kim
WLWoo Je Lee
Woo Je Lee
MLMi Yeon Lee
Mi Yeon Lee
RVRobert Vigersky
Robert Vigersky
Cheol-Young ParkCheol-Young Park
Cheol-Young Park

15 January 2019 in Gut and Liver
Verified
Journal Article
Open access
PDF file
MLMin Jung Lee
Min Jung Lee
EKEun-Hee Kim
Eun-Hee Kim
SBSung-Jin Bae
Sung-Jin Bae
GKGi-Ae Kim
Gi-Ae Kim
SPSung Won Park
Sung Won Park
HKHong-Kyu Kim
Hong-Kyu Kim
Min Jung Lee , Eun-Hee Kim , Sung-Jin Bae , Gi-Ae Kim , Sung Won Park , JaeWon Choe , Chang Hee Jung , Woo Je Lee and Hong-Kyu Kim . Gut and Liver 1999;0:. https://doi.org/10.5009/gnl18070